Opening remarks
|
Tom Maniatis, PhD
Evnin Family Scientific Director and CEO, New York Genome Center
Professor, Zuckerman Institute, Columbia University
|
2:00 pm - 2:30 pm
|
Carlos Cordon-Cardo, MD, PhD
Professor and System-Chair, Pathology, Molecular and Cell Based Medicine; SVP, Pathology and Laboratory Medicine; Mount Sinai Health System; Director, Pathology, Mount Sinai Hospital; Professor, Genetics and Genomic Sciences; Professor, Oncological Sciences, Icahn School of Medicine at Mount Sinai
“COVID-19: Pathophysiology and Staging of a New Disease”
|
2:30 pm - 3:00 pm
|
Jane A McKeating, PhD
Professor of Molecular Virology, University of Oxford, UK
Peter Wing, PhD
Research Fellow, University of Oxford, UK
“Hypoxia and SARS-CoV-2”
|
3:00 pm - 3:30 pm
|
Peter JM Openshaw, MB BS BSc PhD FBS FRCP FMedSci
Professor of Experimental Medicine, Faculty of Medicine, National Heart & Lung Institute, Imperial College London
“Inflammation, disease and immunity in hospitalised patients with Covid”
|
3:30 pm - 4:00 pm
|
Balazs Halmos, MD, MS
Professor, Department of Medicine (Oncology), Albert Einstein School of Medicine; Director, Thoracic Oncology; Director, Clinical Cancer Genomics, Montefiore
“Covid-19 – global impact amongst patients with cancer”
|